General Pathology Lectures

Total Page:16

File Type:pdf, Size:1020Kb

General Pathology Lectures UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE AT URBANA-CHAMPAIGN PATHOLOGY - VOLUME I 2013 - 2014 PATHOLOGY TEACHING FACULTY LIST William Albers, MD Farah Gaudier, MD Ramesh Ramanathan, MD Peoria Department of Pediatrics Dept. of Pathology [email protected] 420 N.E. Glen Oak, Suite 304 Carle Physician Group Peoria, IL 61603 [email protected] Michael Schneider, MD Phone: (309) 655-3453 Dept. of Pediatrics/Genetics [email protected] Nasser Gayed, MD Carle Physician Group Dept. of Med. Info. Sciences [email protected] Jerome Anderson, MD 190 Medical Sciences Bldg Department of Pathology 506 South Mathews Avenue William Scott, MD MPH McDonough District Hosp. Urbana, IL 61801 Clinical Assistant Professor McComb, IL 61455 [email protected] Occupational medicine Phone: (309) 837-2368 Carle Physician Group [email protected] Nicole Howell, MD [email protected] Dept. of Pathology Brett Bartlett, MD Carle Physician Group Richard Tapping, PhD Dept. of Pathology [email protected] Associate Professor. SBL Health Centre Dept. of Microbiology Mattoon, IL 61938 Zheng George Liu, MD [email protected] [email protected] Dept. of Pathology Carle Physician Group Teaching Assistant Frank Bellafiore, MD 602 West University Avenue Brent Beenders, PhD Dept. of Pathology Urbana, IL 61801 [email protected] Carle Physician Group [email protected] 602 West University Avenue Urbana, IL 61801 Naveen Manchanda, MD Pathology Office [email protected] Indiana Univ. Sch. of Medicine Jackie Newman Dept. of Hematology/Oncology Phone: (217) 244-2265 Allan Campbell, MD 525 Barnhill Drive [email protected] Dept. Of Pathology Indianapolis, IN 46202 UICOM Peoria IL [email protected] [email protected] Steve Nandkumar, M.D. Gregory Freund, MD Pathology Course Director Head, Dept. of Pathology 249 Medical Sciences Building 190 Medical Sciences Building 506 South Mathews Avenue 506 South Mathews Avenue Urbana, IL 61801 Urbana, IL 61801 [email protected] [email protected] Page 2 Pathology M-2 Introduction INTRODUCTION Pathology – study of the essential nature of diseases and the structural and functional changes produced by them. ( Pathos= suffering; ologos = study) Pathology consists of two major subdivisions. 1. ANATOMIC PATHOLOGY (AP) This covers surgical pathology, cytopathology, and autopsy pathology. 2. CLINICAL PATHOLOGY (CP) This deals with analyses of body fluids and tissues and involves various disciplines of microbiology, serology, clinical chemistry, hematology, transfusion medicine, cytogenetics, etc. General and systemic pathology (AP) and clinical laboratory sciences (CLS) will be taught throughout the year. General pathology emphasizes cellular and molecular biology, biochemistry, and immunology as they relate to the pathogenesis of disease. Systemic pathology deals with diseases of various “organs and systems”. The clinical laboratory sciences (CLS) course deals with laboratory medicine involving lab testing. It is that branch of clinical pathology that applies scientific laboratory methods relevant to patient care, health promotion and disease prevention. The three pillars of evidence-based medicine are: A. What are the results? B. Are the results valid? C. How are the results applicable to patient care? The CLS course will attempt to answer the above utilizing a clinical “case format”. The significance and implications of lab testing, frequency of tests, turn-around-time (TAT), limitations of lab data, quality control and cost effectiveness will be discussed. The overall approach is to emphasize Lab Testing and how it relates to CLINICAL DIAGNOSIS AND MANAGEMENT. RECOMMENDED TEXTBOOKS 1. Robbins and Cotran Pathologic Basis of Disease by Kumar, Abbas, Fausto, and Aster , 8th edition. HIGHLY RECOMMENDED. 2. Robbins Basic Pathology by Kumar, Abbas, Foster, 9th edition. For the CLS course: - NEED NOT PURCHASE 1. Henry’s Clinical Diagnosis and Management by Laboratory Methods by McPherson and Pincus, 22nd edition, Saunders Publishing Company 2. Interpretation of Diagnostic Tests by Jacques Wallach, M.D., 8th edition, Lippincott, Williams, and Wilkins Publishers (cost about $65.00). Pathology M-2 – Introduction Page 3 3. Widmann’s Clinical Interpretation of Lab Tests, 11th edition, by Ronald Sacher, M.D., and Richard McPherson, M.D. EXAMINATIONS There will be eight interim ( part of integrated exams.) and one final examination. The interim examinations are generated within the department; the final examination is the NBME subject ( shelf) examination in pathology supplied and scored by the National Board of Medical Examiners. Note that the NBME reports a percent correct score along with a scaled score. It is this score that will be used in the final weighting described below. All the questions on the interim exams are multiple choice. There are approximately 80 questions on Foundations integrated examination 1, and roughly 4 questions per teaching/learning session on the other exams. for a total of about 315 MCQs. These numbers are subject to change as thought appropriate by the faculty. Questions on the laboratory sessions will be incorporated as pictures (images) into the examination when applicable. Each of the interim examinations will be weighted in proportion to the number of questions on that examination. Together the interim examinations will constitute 75%, and the final examination (shelf exam – 125 multiple choice questions) 25% of the total weighted score. Should a student fail to achieve a minimum passing level (MPL) for the examination series, the M-2 guidelines as determined by the Office of Student Affairs (including remedial work and a make-up examination) will be followed. The pathology department reserves the right to determine the type of make-up examination. NOTE: UI COM HAS IMPLEMENTED A “FLOATING MPL” SYSTEM DETAILS OF WHICH MAY BE OBTAINED FROM THE OFFICE OF ACADEMIC AFFAIRS. SUFFICE TO SAY THAT THE MPL WILL BE BETWEEN 60 – 65%. Please note that: 1. Students undergoing remediation must take and pass the pathology make-up exam before being allowed further progress in their academic work. 2. The pathology make-up exam will be scheduled on Wed. May 21st 2014 (exact time, place, and type of exam. will be announced later). 3. Delays will not be permitted. Extenuating circumstances will be considered by the Pathology Department on a case by case basis. If you have any questions regarding the curriculum, the course, or the examinations, do not hesitate to contact Dr. Gregory Freund, Head, Department of Pathology, Dr. Steve Nandkumar, Pathology Course Director and Coordinator, or Brent Beenders PhD, Pathology Teaching Assistant. Faculty Department of Pathology “Be not the first by whom the new are tried Nor yet the last to lay the old aside.” Alexander Pope Page 4 Pathology M-2 Introduction UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE Department of Pathology At Urbana-Champaign 190 Medical Sciences Building (MC-714) 506 S Mathews Urbana, IL 61801 August, 2013 Dear Second Year Medical Students: Congratulations on successfully completing the M-1 year and welcome to the M-2 year! As your teaching assistant for Pathology, I will set up teaching sessions and office hours for all M-2 students. Although the sessions are not mandatory, they are highly recommended. The time for our meetings will be determined after school begins and may vary from week to week as we try to find times that work with both your schedules and mine. Most students find pathology to be the most challenging course they have taken so far in medical school. The course content is large and you are required to know the material at a surprising level of detail. I will be providing practice questions, and I hope to take away some of the stress of wondering what the level of questioning will be like. As far as book resources go, the recommended book for the course is “Big” Robbins (Pathologic Basis of Disease; ISBN 978-1-4160-3121-5). Take care not to confuse this book with “Baby” Robins (Basic Pathology; ISBN 978- 1-4377-1781-5), which is smaller because it removes all of the explanatory text and is often much more difficult to understand than “Big” Robbins. Robbins Review of Pathology (ISBN 0721682596) is a question book that I found to be almost indispensable when I took the course. Past students have also recommended Pretest Pathology. You don’t need to buy them as long as you don’t mind sharing the library copies. I think the questions in these books may be a little harder than a typical exam question, but they are representative of the level of difficulty of questions on the NBME pathology shelf-exam that you will take in the spring. Q banks from Kaplan and USMLE World are useful. There are various pathology resources available on the internet. One that I found to be particularly useful was Webpath (http://www-medlib.med.utah.edu/WebPath/webpath.html). This site features images and a large set of review questions. Also, the GRIPE website http://peir.net is available for viewing digitized images. One final note on books: BRS Pathology is a quick review book for USMLE or for organizing your thoughts, but the level of detail in this book may not be sufficient for you to pass the pathology course. Please feel free to contact me by e-mail ([email protected]) with any questions, comments, concerns, or suggestions as the year goes by. Brent Beenders PhD GOALS AND OBJECTIVES Department of Pathology ( please visit the COM M2 web site and go to learning objectives;this password protected site will give you the lecture titles and their corresponding objectives, compiled by pathology faculty members at all four sites) Pathology Course Goals and Objectives By the end of the course, successful students will achieve the level of competence expected of a medical student completing the M2 year, studying for USMLE Step 1, and preparing for the M3 year and patient care responsibilities through the following broad goals and objectives. Specific learning objectives for large and small groups are included at the time of each section.
Recommended publications
  • Modelling of Red Blood Cell Morphological and Deformability Changes During In-Vitro Storage
    applied sciences Article Modelling of Red Blood Cell Morphological and Deformability Changes during In-Vitro Storage Nadeeshani Geekiyanage 1 , Emilie Sauret 1,*, Suvash Saha 2 , Robert Flower 3 and YuanTong Gu 1 1 School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology (QUT), Brisbane City, QLD 4000, Australia; [email protected] (N.G.); [email protected] (Y.G.) 2 School of Mechanical and Mechatronic Engineering, University of Technology Sydney (UTS), Ultimo, NSW 2007, Australia; [email protected] 3 Research and Development, Australian Red Cross Lifeblood, Kelvin Grove, QLD 4059, Australia; [email protected] * Correspondence: [email protected] Received: 28 February 2020; Accepted: 27 April 2020; Published: 4 May 2020 Featured Application: Red blood cell (RBC) storage lesion is a critical issue facing transfusion treatments, and significant changes in RBC morphology and deformability are observed due to the storage lesion. RBCs require high deformability to sustain in-vivo circulation, and impaired deformability leads to several post-transfusion adverse outcomes. Therefore, improved understanding of the interrelation between the morphological and deformability changes and the quality and viability of the stored RBCs is essential to prevent or reduce the transfusion related adverse outcomes. To support this requisite, the influence on RBC deformability due to several aspects of the storage lesion, namely, the changes in cell morphology, surface area and volume, RBC membrane biomechanics, and cytoskeletal structural integrity are explored numerically in this study. Abstract: Storage lesion is a critical issue facing transfusion treatments, and it adversely affects the quality and viability of stored red blood cells (RBCs).
    [Show full text]
  • Eponyms in Digestive System Pathology
    Panacea Journal of Medical Sciences 2020;10(2):58–67 Content available at: https://www.ipinnovative.com/open-access-journals Panacea Journal of Medical Sciences Journal homepage: www.ipinnovative.com Review Article Eponyms in digestive system pathology Ahmad Al Malki1, Hassan Al Solami2, Khalid Al Aboud3,*, Wafa Al Joaid3, Saleha Al Asmary4 1Dept. of Surgery, King Faisal Hospital, Makkah, Saudi Arabia 2Dept. of Gastroenterology, King Faisal Hospital, Makkah, Saudi Arabia 3Dept. of Public Health, King Faisal Hospital, Makkah, Saudi Arabia 4Nursing College, King Saud University, Riyadh, Saudi Arabia ARTICLEINFO ABSTRACT Article history: Eponyms are known type of medical terminology. This mini-review provide highlights on some of the Received 04-05-2020 eponyms of the digestive system pathology. Accepted 06-05-2020 Available online 26-08-2020 © 2020 Published by Innovative Publication. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/) Keywords: Diseases Eponyms Gastroenterology 1. Introduction An eponym is a person, place, or thing after whom or which someone or something is named. There are several anatomical and pathological eponyms in the digestive systems. 1–4 We have reviewed selected eponyms of the digestive system pathology, and present it in a tabulation form in table.1. 5–41 The remarks surrounding the terms and eponyms in the digestive system are no different from those encountered in medicine in general. We are not interested to mention these are remarks, as these have been discussed extentensively in the medical literature. However, we list few examples. Some of the eponyms are no longer in use.
    [Show full text]
  • Special Activities
    59th Annual International Conference of the Wildlife Disease Association Abstracts & Program May 30 - June 4, 2010 Puerto Iguazú Misiones, Argentina Iguazú, Argentina. 59th Annual International Conference of the Wildlife Disease Association WDA 2010 OFFICERS AND COUNCIL MEMBERS OFFICERS President…………………………….…………………...………..………..Lynn Creekmore Vice-President………………………………...…………………..….Dolores Gavier-Widén Treasurer………………………………………..……..……….….……..…….Laurie Baeten Secretary……………………………………………..………..……………….…Pauline Nol Past President…………………………………………………..………Charles van Riper III COUNCIL MEMBERS AT LARGE Thierry Work Samantha Gibbs Wayne Boardman Christine Kreuder Johnson Kristin Mansfield Colin Gillin STUDENT COUNCIL MEMBER Terra Kelly SECTION CHAIRS Australasian Section…………………………..……………………….......Jenny McLelland European Section……………………..………………………………..……….….Paul Duff Nordic Section………………………..………………………………..………….Erik Ågren Wildlife Veterinarian Section……..…………………………………..…………Colin Gillin JOURNAL EDITOR Jim Mills NEWSLETTER EDITOR Jenny Powers WEBSITE EDITOR Bridget Schuler BUSINESS MANAGER Kay Rose EXECUTIVE MANAGER Ed Addison ii Iguazú, Argentina. 59th Annual International Conference of the Wildlife Disease Association ORGANIZING COMMITTEE Executive President and Press, media and On-site Volunteers Conference Chair publicity Judy Uhart Marcela Uhart Miguel Saggese Marcela Orozco Carlos Sanchez Maria Palamar General Secretary and Flavia Miranda Program Chair Registrations Elizabeth Chang Reissig Pablo Beldomenico Management Patricia Mendoza Hebe Ferreyra
    [Show full text]
  • Morphological Study of Human Blood for Different Diseases
    Research Article ISSN: 2574 -1241 DOI: 10.26717/BJSTR.2020.30.004893 Morphological Study of Human Blood for Different Diseases Muzafar Shah1*, Haseena1, Kainat1, Noor Shaba1, Sania1, Sadia1, Akhtar Rasool2, Fazal Akbar2 and Muhammad Israr3 1Centre for Animal Sciences & Fisheries, University of Swat, Pakistan 2Centre for Biotechnology and Microbiology, University of Swat, Pakistan 3Department of Forensic Sciences, University of Swat, Pakistan *Corresponding author: Muzafar Shah, Centre for Animal Sciences & Fisheries, University of Swat, Pakistan ARTICLE INFO ABSTRACT Received: August 25, 2020 The aim of our study was the screening of blood cells on the basis of morphology for different diseased with Morphogenetic characters I e. ear lobe attachment, clinodactyly Published: September 07, 2020 and tongue rolling. For this purpose, 318 blood samples were collected randomly. Samples were examined under the compound microscopic by using 100x with standard Citation: Muzafar Shah, Haseena, method. The results show 63 samples were found normal while in 255 samples, different Kainat, Noor Shaba, Sania, Sadia, et al. types of morphological changes were observed which was 68.5%, in which Bite cell 36%, Morphological Study of Human Blood for Elliptocyte 34%, Tear drop cell 30%, Schistocyte 26%, Hypochromic cell 22.5%, Irregular Different Diseases. Biomed J Sci & Tech Res contracted cell 16%, Echinocytes 15.5%, Roleaux 8%, Boat shape 6.5%, Sickle cell 5%, Keratocyte 4% and Acanthocytes 1.5%. During the screening of slides, bite cell, elliptocyte, tear drop cell, schistocytes, hypochromic cell, irregular contracted cells were found 30(1)-2020.Keywords: BJSTR.Human MS.ID.004893. blood; Diseases; frequently while echinocytes, boat shape cell, acanthocytes, sickle cells and keratocytes Morphological; Acanthocytes; Keratocyte were found rarely.
    [Show full text]
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Distribution of Bronchial Gland Measurements in a Jamaican Population
    Thorax: first published as 10.1136/thx.24.5.619 on 1 September 1969. Downloaded from Thorax (1969), 24, 619. Distribution of bronchial gland measurements in a Jamaican population J. A. HAYES1 From the Pathology Department, University of the West Indies, Mona, Kingston 7, Jamaica Measurements of the gland thickness and Reid index have been made on bronchi obtained at necropsy on 53 male and 52 female Jamaicans. The mean values for the Reid index and mucous gland thickness obtained were 0-314 and 0O192 mm. for males, and 0-302 and 0l170 mm. for females respectively. No significant increase in value was seen with age, although the data suggest this trend. The results have been compared with data published from Montreal and the same overall Gaussian distribution is seen. This supports the suggestion that the gland measurements in non-bronchitic and bronchitic subjects do- not fall into two distinct groups but are part of a continuous distribution. The similarity of the two studies is also of interest as the populations are drawn from two distinct environments, one from a non-industrialized tropical island, the other from a large city in the northern hemisphere. Bronchial mucous gland enlargement is usually The existing evidence, therefore, indicates that associated with the consistent production of atmospheric pollution is connected with enlarge- copyright. mucoid sputum in chronic bronchitis (Reid, 1958). ment of bronchial mucous glands. It was suggested that this mucosal change could Clinical chronic bronchitis is encountered in be recognized by an increase in the ratio of Jamaica, apparently in the absence of atmospheric mucous gland thickness to thickness of the pollution (Walshe and Hayes, 1967).
    [Show full text]
  • A Novel Splice Site Indel Alteration in the EIF2AK3 Gene Is Responsible For
    Sümegi et al. BMC Medical Genetics (2020) 21:61 https://doi.org/10.1186/s12881-020-0985-6 RESEARCH ARTICLE Open Access A novel splice site indel alteration in the EIF2AK3 gene is responsible for the first cases of Wolcott-Rallison syndrome in Hungary Andrea Sümegi1, Zoltán Hendrik2, Tamás Gáll1, Enikő Felszeghy3, Katalin Szakszon3, Péter Antal-Szalmás4, Lívia Beke2, Ágnes Papp3, Gábor Méhes2, József Balla1,5 and György Balla1,3* Abstract Background: Wolcott-Rallison Syndrome (WRS) is a rare autosomal recessive disease that is the most common cause of neonatal diabetes in consanguineous families. WRS is caused by various genetic alterations of the Eukaryotic Translation Initiation Factor 2-Alpha Kinase 3 (EIF2AK3) gene. Methods: Genetic analysis of a consanguineous family where two children were diagnosed with WRS was performed by Sanger sequencing. The altered protein was investigated by in vitro cloning, expression and immunohistochemistry. Results: The first cases in Hungary, − two patients in one family, where the parents were fourth-degree cousins - showed the typical clinical features of WRS: early onset diabetes mellitus with hyperglycemia, growth retardation, infection-induced multiple organ failure. The genetic background of the disease was a novel alteration in the EIF2AK3 gene involving the splice site of exon 11– intron 11–12 boundary: g.53051_53062delinsTG. According to cDNA sequencing this created a new splice site and resulted in a frameshift and the development of an early termination codon at amino acid position 633 (p.Pro627AspfsTer7). Based on in vitro cloning and expression studies, the truncated protein was functionally inactive. Immunohistochemistry revealed that the intact protein was absent in the islets of pancreas, furthermore insulin expressing cells were also dramatically diminished.
    [Show full text]
  • The Influence of Magnetic Fields on Selected Physiological Parameters
    bioRxiv preprint doi: https://doi.org/10.1101/497990; this version posted December 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The Influence of Magnetic Fields on Selected Physiological 2 Parameters of Blood and Tissues in Mice 3 Hani M. Abdelsalama and Mohammed Elywab 4 a Department of Zoology, Faculty of Science, Zagazig University 5 b Department of Biophysics, Faculty of Science, Zagazig University 6 Running title: Effect of magnetic fields on antioxidants and enzymes 7 Manuscript pages: 19, Figures: 7, Tables: 7. 8 *Corresponding author: 9 Hani M. Abdelsalam 10 Department of Zoology, Faculty of Science, Zagazig University Tel.:0020552303252 11 Tel.: +201008051012 E-mail:[email protected] 12 Co-author: 13 Mohammed Elywa E-mail: [email protected] 14 15 Abstract 16 This study aimed to highlight the influence of exposure to different applied magnetic fields (MFs) on 17 SOD, MDA and GSH levels in the liver, LDH and CPK activities in the muscle and γ-aminobutyric acid levels 18 in the brain, as well as some haematological parameters. Adult male albino Swiss mice were divided into 5 19 equal groups (n = 6), the control group (untreated) and four exposure groups that were exposed to MFs of 20, 20 40, 60 and 80 Gauss for 5 min/day for 5 days.: Exposure to MFs induced significant decreases in total GSH 21 levels and SOD activity but a significant increase in MDA levels in the liver.
    [Show full text]
  • Methodical Instruction for Lectures
    Ministry of Public Health of Ukraine Ukrainian Medical Stomatological Academy Approved at the meeting of the department Infection diseases and epidemiology «28» August 2019 protocol № 1 from «28» August 2019 the Head of the Department _________ Koval T.I. Methodical Instruction for lectures Study discipline Infectious diseases and epidemiology Module № Infectious diseases and epidemiology Topic Acute respiratory viral infections. Clinical characteristics and prevention of influenza. Course 4 Faculty Stomatological Number of teaching hours: 2 Poltava -2019 1. Scientific and methodological substantiation of the topic. Infectious diseases today remain extremely relevant. In the past decades, previously unknown infections — HIV infection, Lyme disease, campylobacteriosis, SARS, and others — have spread, and the achieved reduction in the incidence of diphtheria and measles has not been maintained. There is an increase in the incidence of viral hepatitis, acute intestinal infectious diseases, tuberculosis among the population of Ukraine and other countries. The clinical manifestations of infectious diseases can be different, often atypical, can lead to hospitalization of the patient in a medical institution of any profile. The ability to recognize infectious pathology, correctly conduct differential diagnosis, prescribe appropriate treatment, ensure that the necessary preventive measures are taken that are necessary for a doctor of any specialty. In our country, the classification of infectious diseases, academician L.V. Gromashevsky, has become most widespread. The classification is based on the principle of the predominant localization of the pathogen in the body, which is due to a certain transmission mechanism. One of the most important components in the treatment of patients for infectious diseases is inpatient treatment. Infectious Diseases Hospital is a special medical institution, which has a number of structural and functional units in order to ensure effective treatment, examination and isolation of patients.
    [Show full text]
  • TOPIC 5 Lab – B: Diagnostic Tools & Therapies – Blood & Lymphatic
    TOPIC 5 Lab – B: Diagnostic Tools & Therapies – Blood & Lymphatic Disorders Refer to chapter 17 and selected online sources. Refer to the front cover of Gould & Dyer for normal blood test values. Complete and internet search for videos from reliable sources on blood donations and blood tests. Topic 5 Lab - A: Blood and Lymphatic Disorders You’ll need to refer to an anatomy & physiology textbook or lab manual to complete many of these objectives. Blood Lab Materials Prepared slides of normal blood Prepared slides of specific blood pathologies Models of formed elements Plaque models of formed elements Blood typing model kits Blood Lab Objectives – by the end of this lab, students should be able to: 1. Describe the physical characteristics of blood. 2. Differentiate between the plasma and serum. 3. Identify the formed elements on prepared slides, diagrams and models and state their main functions. You may wish to draw what you see in the space provided. Formed Element Description / Function Drawing Erythrocyte Neutrophil s e t y c Eosinophils o l u n a r Basophils Leukocytes G e Monocytes t y c o l u n Lymphocytes a r g A Thrombocytes 4. Define differential white blood cell count. State the major function and expected range (percentage) of each type of white blood cell in normal blood. WBC Type Function Expected % Neutrophils Eosinophils Basophils Monocytes Lymphocytes 5. Calculation of the differential count? 6. Define and use in proper context: 1. achlorhydria 5. amyloidosis 2. acute leukemia 6. anemia 3. agnogenic myeloid metaplasia 7. autosplenectomy 4. aleukemic leukemia 8. basophilic stippling 9.
    [Show full text]
  • Obstructive Lung Diseases
    Obstructive Lung Diseases @pathology434 Objectives: ● Understand that this group of disorders is characterized by an increase in resistance to airflow, owing to partial or complete obstruction at any level of the bronchial/ bronchiolar. ● Know that the major obstructive disorders are chronic bronchitis, emphysema, asthma and bronchiectasis. ● Is aware that the symptom common to all these disorders is "dyspnea" (difficulty in breathing) Chronic bronchitis and emphysema almost always coexists. Important note: ​During the previous blocks, we noticed some mistakes just before the exam and we didn’t have the time to edit the files. To make sure that all students are aware of any changes, please check out this link before viewing the file to know if there are any additions or changes. The same link will be used for all of our work: ​Pathology Edit 1 Introduction. There are four disorders in this group: emphysema, chronic bronchitis, asthma, and bronchiectasis. - Emphysema and chronic bronchitis often are clinically grouped together under the name of ​chronic obstructive pulmonary disease​ (​COPD​). ​COPD affects more than 10% of the U.S. adult population and is the fourth leading cause of death in this country. What’s the difference between Asthma & COPD? Asthma is reversible, while COPD is irreversible. Before we start with specific diseases we would like to start by talking about amyloidosis, a complication of chronic diseases. ​(For full information: Robbins p153) Amyloidosis:​ ​is a condition in which extracellular deposits of misfolded proteins lead to tissue damage. There are several forms of amyloidosis. Two of them are of interest in our lesson: ​AA​ & ​AL ● AA:​ This is the one that is increased in chronic inflammation.
    [Show full text]
  • Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
    92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, ␤3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣6␤4 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1
    [Show full text]